Clinical Scorecard: The Role of Tryptophan in Influencing Prolactin's Effects on Insomnia Among Perimenopausal Women: A Cross-Sectional Analysis
At a Glance
Category
Detail
Condition
Key Mechanisms
Association between prolactin levels and insomnia severity moderated by tryptophan levels, as evidenced by correlation and regression analyses.
Target Population
Care Setting
Key Highlights
Insomnia is prevalent in 80%-90% of perimenopausal women.
Prolactin levels correlate positively with insomnia severity and psychological distress.
Tryptophan levels moderate the relationship between prolactin and insomnia severity, with significant statistical support.
Guideline-Based Recommendations
Diagnosis
Management
Consider dietary interventions to increase tryptophan intake, supported by evidence from the study.
Explore pharmacological options targeting prolactin levels, including potential side effects.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Tryptophan supplementation may improve sleep quality and mitigate insomnia, supported by clinical findings.
Clinical Best Practices
Incorporate screening for insomnia and mental health in routine assessments of perimenopausal women, emphasizing the bidirectional relationship between mood and sleep.
Educate patients on the role of diet in managing insomnia symptoms, particularly the impact of tryptophan.
